🇺🇸 FDA
Pipeline program

umbilical cord mesenchymal stem cells

13ZCZDSY02200

Phase 2 mab completed

Quick answer

umbilical cord mesenchymal stem cells for Peripheral Arterial Disease is a Phase 2 program (mab) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Peripheral Arterial Disease
Phase
Phase 2
Modality
mab
Status
completed

Clinical trials